Cart
sales@molnova.com
Opevesostat
CAS No. 2231294-96-3
Opevesostat( —— )
Catalog No. M37000 CAS No. 2231294-96-3
Opevesostat (ODM-208) is an inhibitor of lyase (CYP11A1) (the enzyme cleavage cholesterol side chain).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 67 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 101 | In Stock |
|
| 25MG | 188 | In Stock |
|
| 50MG | 291 | In Stock |
|
| 100MG | 431 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOpevesostat
-
NoteResearch use only, not for human use.
-
Brief DescriptionOpevesostat (ODM-208) is an inhibitor of lyase (CYP11A1) (the enzyme cleavage cholesterol side chain).
-
DescriptionOpevesostat is a cholesterol side-chain cleavage enzyme (CYP11A1) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorP450
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2231294-96-3
-
Formula Weight418.51
-
Molecular FormulaC21H26N2O5S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (119.47 mM; Ultrasonic )
-
SMILESC(N1CC=2C(C1)=CC=CC2)C3=CC(=O)C(OCC4CCN(S(C)(=O)=O)CC4)=CO3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ikonen, et al. Method for treating prostate cancer in patient using CYP11A1 inhibitor as active ingredient. World Intellectual Property Organization, WO2023052682 A1. 2023-04-06.
molnova catalog
related products
-
N-desmethyl Olanzapi...
N-desmethyl Olanzapine is a metabolite of the atypical antipsychotic compound Olanzapinec, which is formed through the oxidative metabolism of olanzapine by the cytochrome 450 (CYP) isoenzyme CYP1A2.
-
Toddalolactone
anti-inflammatory and analgesic.
-
N-Nornuciferine hydr...
N-Nornuciferine is an aporphine alkaloid in lotus leaf, significantly inhibits CYP2D6 (IC50: 3.76 μM, Ki: 2.34 μM).N-Nornuciferine strongly inhibits CYP2D6 activity but shows weak or no inhibition of the other four P450 isoenzymes (CYP2C19, CYP3A4, CYP2E1, CYP2C9). N-Nornuciferine competitively inhibits the CYP2D6-catalyzed dextromethorphan O-demethylation (Ki: 2.34 μM).
